BACKGROUND: Individuals with schizotypal personality disorder (SPD) exhibit impaired cognitive functioning in a pattern similar to that found in schizophrenia; less clear is the extent to which these individuals also share schizophrenia patients' impairments in functional capacity and real-world functioning. METHOD: We evaluated 46 SPD patients, as well as 38 individuals with avoidant personality disorder (AvPD) and 55 healthy controls (HC) on: cognitive functioning, real-world functioning (employment and residential status), and functional capacity (indexed by the UPSA, a performance-based skills assessment). RESULTS: We found that individuals with SPD exhibited worse performance on both the cognitive battery and the UPSA than the other groups; they were also less likely to be employed and to be living independently. Additionally, cognitive and UPSA performance in the SPD group was intercorrelated to a degree comparable to what has been found in schizophrenia, and this relationship was not present in the AvPD group. Finally, real-world functioning was related to UPSA performance for both patient groups. CONCLUSIONS: SPD patients exhibit impaired real-world functioning suggesting that these deficits extend across the schizophrenia spectrum. In addition, there is supportive evidence for the validity and importance of performance-based measures such as the UPSA to predict everyday outcomes across the schizophrenia spectrum. Published by Elsevier B.V.
BACKGROUND: Individuals with schizotypal personality disorder (SPD) exhibit impaired cognitive functioning in a pattern similar to that found in schizophrenia; less clear is the extent to which these individuals also share schizophreniapatients' impairments in functional capacity and real-world functioning. METHOD: We evaluated 46 SPD patients, as well as 38 individuals with avoidant personality disorder (AvPD) and 55 healthy controls (HC) on: cognitive functioning, real-world functioning (employment and residential status), and functional capacity (indexed by the UPSA, a performance-based skills assessment). RESULTS: We found that individuals with SPD exhibited worse performance on both the cognitive battery and the UPSA than the other groups; they were also less likely to be employed and to be living independently. Additionally, cognitive and UPSA performance in the SPD group was intercorrelated to a degree comparable to what has been found in schizophrenia, and this relationship was not present in the AvPD group. Finally, real-world functioning was related to UPSA performance for both patient groups. CONCLUSIONS: SPD patients exhibit impaired real-world functioning suggesting that these deficits extend across the schizophrenia spectrum. In addition, there is supportive evidence for the validity and importance of performance-based measures such as the UPSA to predict everyday outcomes across the schizophrenia spectrum. Published by Elsevier B.V.
Authors: Michael F Green; Nina R Schooler; Robert S Kern; Fred J Frese; Wendy Granberry; Philip D Harvey; Craig N Karson; Nancy Peters; Michelle Stewart; Larry J Seidman; John Sonnenberg; William S Stone; David Walling; Ellen Stover; Stephen R Marder Journal: Am J Psychiatry Date: 2011-02-01 Impact factor: 18.112
Authors: Christopher R Bowie; Colin Depp; John A McGrath; Paula Wolyniec; Brent T Mausbach; Mary H Thornquist; James Luke; Thomas L Patterson; Philip D Harvey; Ann E Pulver Journal: Am J Psychiatry Date: 2010-05-17 Impact factor: 18.112
Authors: Feea R Leifker; Thomas L Patterson; Christopher R Bowie; Brent T Mausbach; Philip D Harvey Journal: Schizophr Res Date: 2010-06 Impact factor: 4.939
Authors: James M Gold; Deanna M Barch; Cameron S Carter; Steven Dakin; Steven J Luck; Angus W MacDonald; J Daniel Ragland; Charan Ranganath; Ilona Kovacs; Steven M Silverstein; Milton Strauss Journal: Schizophr Bull Date: 2011-11-17 Impact factor: 9.306
Authors: Samir Sabbag; Elizabeth M Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson; Philip D Harvey Journal: Schizophr Res Date: 2011-05-26 Impact factor: 4.939
Authors: Belinda J McIntosh; Xiang Yang Zhang; Thomas Kosten; Shu Ping Tan; Mei Hong Xiu; Jeffrey Rakofsky; Philip D Harvey Journal: J Psychiatr Res Date: 2011-03-02 Impact factor: 4.791
Authors: Philip D Harvey; Lars Helldin; Christopher R Bowie; Robert K Heaton; Anna-Karin Olsson; Fredrik Hjärthag; Torsten Norlander; Thomas L Patterson Journal: Am J Psychiatry Date: 2009-06-01 Impact factor: 18.112
Authors: Christopher R Bowie; Abraham Reichenberg; Margaret M McClure; Winnie L Leung; Philip D Harvey Journal: Schizophr Res Date: 2007-11-28 Impact factor: 4.939
Authors: Margaret M McClure; Fiona Graff; Joseph Triebwasser; Mercedes Perez-Rodriguez; Daniel R Rosell; Harold Koenigsberg; Erin A Hazlett; Larry J Siever; Philip D Harvey; Antonia S New Journal: Am J Psychiatry Date: 2019-01-18 Impact factor: 18.112
Authors: Waqas Ullah Khan; Zaid Ghazala; Heather Jane Brooks; Ponnusamy Subramaniam; Benoit H Mulsant; Sanjeev Kumar; Aristotle N Voineskos; Daniel M Blumberger; Robert S Kern; Tarek K Rajji Journal: Schizophr Bull Date: 2021-01-23 Impact factor: 9.306
Authors: Philip R Szeszko; Suril Gohel; Daniel H Vaccaro; King-Wai Chu; Cheuk Y Tang; Kim E Goldstein; Antonia S New; Larry J Siever; Margaret McClure; M Mercedes Perez-Rodriguez; M Mehmet Haznedar; William Byne; Erin A Hazlett Journal: Psychiatry Res Neuroimaging Date: 2022-02-19 Impact factor: 2.493
Authors: Erin A Hazlett; Ethan G Rothstein; Rui Ferreira; Jeremy M Silverman; Larry J Siever; Ann Olincy Journal: Schizophr Res Date: 2014-12-05 Impact factor: 4.939
Authors: Chi C Chan; Philip R Szeszko; Edmund Wong; Cheuk Y Tang; Caitlin Kelliher; Justin D Penner; M Mercedes Perez-Rodriguez; Daniel R Rosell; Margaret McClure; Panos Roussos; Antonia S New; Larry J Siever; Erin A Hazlett Journal: Schizophr Res Date: 2018-02-14 Impact factor: 4.662
Authors: Shelagh Szabo; Elizabeth Merikle; Greta Lozano-Ortega; Lauren Powell; Thomas Macek; Stephanie Cline Journal: Schizophr Res Treatment Date: 2018-12-27